ISPE announced its 2018 Quality Manufacturing Conference, taking place 4 – 6 June in Arlington, Virginia USA. Broad regulatory involvement throughout this signature conference makes it the ideal setting for pharmaceutical professionals to gain a clear understanding of current regulatory perspectives on quality manufacturing topics—including quality agreements, API starting materials, human error prevention, contamination control, and patient-centric specification.
“Our program committee is very passionate about quality initiatives and making sure we're doing the right things to manufacture high-quality drugs. We are working very closely with our regulatory colleagues to identify cutting-edge topics and concepts related to GMP for global supply and future possibilities.”
Timothy Watson, PhD
Senior Director, GCMC Advisory Office Pfizer, Inc
This event will feature global industry experts and regulators, including:
The Quality Manufacturing Conference will be held as part of three key events recognizing the pharmaceutical and biopharmaceutical industry’s efforts to improve product quality and patient health during the 2018 ISPE Pharmaceutical Quality Week. This week will also feature the Continuous Manufacturing Workshop focusing on manufacturing technologies and regulatory approaches for successful development, implementation, and lifecycle management. In addition, five in-depth pharma training courses will be offered: biopharmaceutical manufacturing facilities, GAMP® 5, oral solid dosage (OSD), Quality by Design (QbD), and commissioning and qualification (C&Q).